Inventia Healthcare is a finished-dose manufacturer based in India. It appears in 149 regulatory filings across 16 regulators, without an active US DMF or CEP on file. Its filings concentrate with JFDA (JO), BOMRA (BW) and ARCSA (EC). Its GMP standing is certified by EMA, NAFDAC (NG) and ANVISA (Brazil), among 6 authorities. Its most recent recorded inspection, by US FDA, closed on 12 February 2025 as VAI. Customs aggregates show $65.0M of exports covering 1,405 molecules to 47 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Maharashtra State, United Arab Emirates | Not on file |
| AMBARNATH, India | Not on file |
| DISTRICT THANE, India | Not on file |
| Thane, India | 3008232264 |
| Thane, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| JFDA (JO) | 30 | None |
| BOMRA (BW) | 24 | None |
| ARCSA (EC) | 17 | None |
| NAFDAC (NG) | 17 | 2 |
| UZPHARM (UZ) | 11 | None |
| NCELS (KZ) | 9 | None |
| EMA | None | 2 |
| ANVISA (Brazil) | None | 2 |
| FDA (GH) | None | 1 |
| US FDA | None | 1 |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $11.0M | 21 |
| 2025 | Not reported | $65.0M | 47 |
| 2024 | Not reported | $57.8M | 45 |
| 2023 | Not reported | $68.0M | 40 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Inventia Healthcare comes back tiered against every other supplier able to file there.
Start for free